Literature DB >> 9180277

Regulation of the DNA binding of p53 by its interaction with protein kinase CK2.

A Prowald1, N Schuster, M Montenarh.   

Abstract

Some of the numerous functions of the growth suppressor protein p53 are regulated by its interaction with viral and cellular proteins. C-terminal sequences of p53 are implicated in binding to the regulatory beta-subunit of protein kinase CK2. Using a p53-specific DNA binding element we found that the beta-subunit of CK2 inhibited the DNA binding of p53 whereas the alpha-subunit had no influence. The CK2 holoenzyme consisting of two alpha- and two beta-subunits led to a supershift in DNA binding of p53 similar to the p53-specific monoclonal antibody PAb421 as well as the C-terminus of p53. Thus, our results showed an individual role of the free beta-subunit of CK2 on the DNA binding activity of p53.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9180277     DOI: 10.1016/s0014-5793(97)00399-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Protein kinase CK2 interacts with a multi-protein binding domain of p53.

Authors:  C Götz; P Scholtes; A Prowald; N Schuster; W Nastainczyk; M Montenarh
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Localization of individual subunits of protein kinase CK2 to the endoplasmic reticulum and to the Golgi apparatus.

Authors:  M Faust; M Jung; J Günther; R Zimmermann; M Montenarh
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

Review 3.  Emergence of protein kinase CK2 as a key target in cancer therapy.

Authors:  Janeen H Trembley; Zhong Chen; Gretchen Unger; Joel Slaton; Betsy T Kren; Carter Van Waes; Khalil Ahmed
Journal:  Biofactors       Date:  2010 May-Jun       Impact factor: 6.113

Review 4.  Induction and activation of the p53 pathway: a role for the protein kinase CK2?

Authors:  David W Meek; Miranda Cox
Journal:  Mol Cell Biochem       Date:  2011-07-19       Impact factor: 3.396

Review 5.  CK2 and the Hallmarks of Cancer.

Authors:  May-Britt Firnau; Angela Brieger
Journal:  Biomedicines       Date:  2022-08-16

Review 6.  Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.

Authors:  J H Trembley; G Wang; G Unger; J Slaton; K Ahmed
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

7.  Translation Control by p53.

Authors:  Justina Kasteri; Dibash Das; Xuelin Zhong; Leah Persaud; Ashleigh Francis; Hilal Muharam; Moira Sauane
Journal:  Cancers (Basel)       Date:  2018-05-05       Impact factor: 6.639

Review 8.  Targeting protein kinase CK2 in the treatment of cholangiocarcinoma.

Authors:  Padma-Sheela Jayaraman; Kevin Gaston
Journal:  Explor Target Antitumor Ther       Date:  2021-10-31

9.  Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells.

Authors:  Sabrina Manni; Alessandra Brancalion; Elisa Mandato; Laura Quotti Tubi; Anna Colpo; Marco Pizzi; Rocco Cappellesso; Fortunato Zaffino; Speranza Antonia Di Maggio; Anna Cabrelle; Filippo Marino; Renato Zambello; Livio Trentin; Fausto Adami; Carmela Gurrieri; Gianpietro Semenzato; Francesco Piazza
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.